Device US - Ultrasound Systems

Acuson Sequoia Diagnostic Ultrasound System

Payments companies reported to CMS as associated with Acuson Sequoia Diagnostic Ultrasound System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$101Kassociated payments (2023-2025)
505clinicians with associated payments
1company reporting

By year

2023 $50K
2024 $19K
2025 $32K

Payments reported as associated with Acuson Sequoia Diagnostic Ultrasound System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $54K
Cardiovascular Disease $14K
Anesthesiology $5,535
Pediatric Radiology $4,720
Interventional Cardiology $3,578
Clinical Cardiac Electrophysiology $3,415

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Acuson Sequoia Diagnostic Ultrasound System

These are the largest totals companies reported as associated with Acuson Sequoia Diagnostic Ultrasound System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Sean Raj Dallas, TX Diagnostic Radiology $8,192.23
Richard Barr Youngstown, OH Diagnostic Radiology $6,763.83
David Fetzer Dallas, TX Diagnostic Radiology $5,900.00
Michael Racenstein Elk Grove Village, IL Diagnostic Radiology $5,355.00
Erika Rubesova Stanford, CA Pediatric Radiology $4,080.00
Robert Percell Lincoln, NE Cardiovascular Disease $2,720.00
Michael Forney Cleveland, OH Diagnostic Radiology $2,641.61
Madelene Lewis Charleston, SC Diagnostic Radiology $1,937.26
Maria Artze Weston, FL Diagnostic Radiology $1,734.78
Craig Tuohy Bellevue, WA Cardiovascular Disease $1,700.00

Prescribed Acuson Sequoia Diagnostic Ultrasound System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.